DGAP-News: SHOP APOTHEKE EUROPE: PROCESSED THE FIRST E-PRESCRIPTION.EQS
Im Artikel erwähnte Wertpapiere: Shop Apotheke Europe
DGAP-News: SHOP APOTHEKE EUROPE N.V.
/ Key word(s): Miscellaneous
SHOP APOTHEKE EUROPE: PROCESSED THE FIRST E-PRESCRIPTION.
SHOP APOTHEK EUROPE has prepared for the introduction of electronic prescriptions (e-Rx) for more than two years and has been ready since this summer. The processing of the first e-Rx demonstrates that all of SHOP APOTHEKE EUROPE's front- and back-end processes are working smoothly. The gematik e-Rx pilot in Germany started in the Berlin-Brandenburg focus region this July.
Following the ongoing pilot phase and a nationwide introduction phase in December, e-prescriptions are expected to become mandatory for all drugs prescribed to people covered by statutory insurance in Germany from 1 January 2022 or later that year. Germany-based patients will then be able to submit their prescriptions directly in the webshop or via the SHOP APOTHEKE app.
SHOP APOTHEKE EUROPE customers will continue to be able to send a paper prescription by regular mail - so patients can choose the method that best fits their needs. However, SHOP APOTHEKE EUROPE expects e-prescriptions to become the standard in Germany after the launch phase: "We expect that our customers will rapidly adopt e-prescriptions and the convenience they offer. Digital services are now part of life for all age groups and we are pleased that we can finally offer our customers this safe and fast way of filling their prescriptions," says Chief Commercial Officer and co-founder Stephan Weber.
ABOUT SHOP APOTHEKE EUROPE.
Headquartered in the Dutch logistics hub of Sevenum near Venlo with locations in Cologne, Berlin, Munich, Tongeren, Warsaw, Milan, Paris and Eindhoven, SHOP APOTHEKE EUROPE offers its customers a broad range of more than 100,000 original products at attractive prices: OTC, beauty and personal care products as well as prescription drugs, supplemented by high quality natural food and health products, low carb products and sports nutrition. Currently, more than 7 million active customers trust SHOP APOTHEKE EUROPE.
Since safe and reliable pharmaceutical advice are top priorities at SHOP APOTHEKE EUROPE, the e-pharmacy provides comprehensive pharmaceutical consulting services.
In preparation for the introduction of electronic prescriptions in Germany in summer 2021, the company will further improve the customer experience with focus on disease-specific digital medication management services following the acquisition of SMARTPATIENT in January 2021. This is a key part of SHOP APOTHEKE EUROPE's strategy to transform itself from a pure online retailer into a truly customer-centric e-pharmacy platform.
SHOP APOTHEKE EUROPE N.V. has been listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) since 2016 and is part of the SDAX stock index.
Trade and popular media:
02.11.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
|Company:||SHOP APOTHEKE EUROPE N.V.|
|Dirk Hartogweg 14|
|5928 LV Venlo|
|Phone:||0800 - 200 800 300|
|Fax:||0800 - 90 70 90 20|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||1245248|
|End of News||DGAP News Service|